The Motley Fool

Key Data Points

Primary metrics and data points about Geron Corp.
Current Price: $3.94
Prev Close: $4.02
Open: $4.02
Bid: $3.89
Ask: $4.07
Day's Range: $3.89 - $4.06
52wk Range: $1.76 - $4.49
Volume: 1,339,335
Avg Vol 2,528,522
Market Cap: $624M
P/E (ttm): -17.48
EPS (ttm): ($0.23)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Geron Corp from Fool.com.

Business Summary

Industry, sector and description for Geron Corp.

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GERN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Geron Corp.
CAPS Rating 3 out of 5
 
632 Outperform
61 Underperform
CAPS All Stars
 
102 Outperform
19 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Scarlett, CEO

100% Approve

Based on 1 Ratings

More Details for GeronJobs

Powered by

More Details about Geron Corp

Primary metrics and data points about Geron Corp.